Plus   Neg

Teva Pharmaceutical Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Israeli generic medicines producer Teva Pharmaceutical Industries Ltd. (TEVA) raised its earnings and revenue guidance for the full-year 2019.

For fiscal 2019, the company now projects earnings in a range of $2.30 to $2.50 per share on net revenues between $17.2 billion and $17.4 billion.

Previously, the company expected earnings in a range of $2.20 to $2.50 per share on net revenues between $17.0 billion and $17.4 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.38 per share on revenue of $17.18 billion for the year. Analysts' estimates typically exclude special items.

The company also said it remains on track to achieve its two-year restructuring target of a $3 billion spend base reduction.

Kåre Schultz, Teva's President and CEO, said, "Looking ahead, we are committed to driving long-term shareholder value by maximizing profits from existing core businesses, increasing sales of new brands and products, executing our biosimilar/biologics strategy, delivering manufacturing efficiencies, and generating strong free cash flow for debt repayment."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Panera Bread Co. is launching a new subscription program that will allow customers to drink unlimited coffee and tea. The new program of $8.99 per month launches Thursday and covers hot coffee, iced coffee and hot tea. With the introduction of the subscription, Panera becomes the first national restaurant company to offer unlimited hot drip coffee, iced coffee and hot tea for $8.99 per month. Best Buy Co. Inc. (BBY) Thursday reported a fourth-quarter profit that increased 1.4 percent from last year, while, J. C. Penney Co.'s (JCP) quarterly profit dropped 64 percent. However, the results of the companies topped analysts' estimates. Safavieh LLC recalled about 760 units of Aura and Silas 3-Drawer Chests for possible serious tip-over and entrapment hazards that can result in death or injuries to children, the U.S. Consumer Product Safety Commission said in a statement. The company said the chests are unstable if they are not anchored to the wall.
Follow RTT